My Hair Started Falling Out After Switching Weight-Loss Medications—Could Semaglutide or Tirzepatide Be the Cause?

Noticing handfuls of hair in the shower or unusually large amounts of hair on your brush can be alarming—especially when the shedding seems to begin suddenly.

Many patients using medications such as semaglutide or tirzepatide wonder whether the medication itself is damaging their hair. In many cases, however, the connection is more complicated.

Recently, a 47-year-old woman visited our dermatology clinic after developing sudden, generalized scalp shedding over approximately two months. She had no itching, burning, pain, or visible scalp inflammation. She also denied a history of anemia, thyroid disease, recent surgery, or recent infection.

During her consultation, she shared that she had experienced medical complications earlier in the year and had also switched from semaglutide to tirzepatide.

Her scalp examination and positive hair-pull test were most consistent with telogen effluvium, a form of diffuse hair shedding that can occur after physical stress, hormonal changes, medication changes, nutritional deficiencies, or significant weight loss.

The Patient’s Hair-Loss Story

The patient reported that her hair loss was:

  • Sudden in onset

  • Generalized across the scalp

  • Moderate in severity

  • Present for approximately two months

  • Not associated with scalp itching or pain

  • Not currently being treated

A close scalp and hair examination showed diffuse shedding, particularly through the mid-frontal scalp.

A hair-pull test was positive for telogen hairs, supporting the diagnosis of telogen effluvium.

What Is Telogen Effluvium?

Telogen effluvium is a temporary form of excessive hair shedding.

Hair follicles normally cycle through several phases:

  1. Anagen: Active growth

  2. Catagen: Transition

  3. Telogen: Resting phase

  4. Exogen: Shedding

When the body experiences significant stress, a larger-than-normal number of follicles may enter the resting phase at the same time.

Several weeks or months later, those hairs begin to shed.

Patients may notice:

  • More hair in the shower drain

  • Increased hair on brushes or pillows

  • A smaller ponytail

  • Diffuse scalp visibility

  • Sudden shedding without completely bald patches

Because the shedding often begins well after the original trigger, many people do not immediately connect the two events.

Can Semaglutide or Tirzepatide Cause Hair Loss?

Patients using GLP-1 or related weight-loss medications sometimes report increased hair shedding.

The medication may not directly injure the follicles. Instead, shedding may develop because of factors associated with treatment, such as:

  • Rapid weight loss

  • Reduced calorie intake

  • Inadequate protein consumption

  • Iron or vitamin deficiencies

  • Physical stress on the body

  • Hormonal and metabolic changes

  • Medication transitions

  • Underlying illness

In this patient’s case, both her earlier medical complications and her switch from semaglutide to tirzepatide were considered possible contributing factors.

The timing of the shedding and positive hair-pull test supported telogen effluvium.

Does Rapid Weight Loss Trigger Hair Shedding?

Yes.

Significant or rapid weight loss is a common trigger for telogen effluvium.

When the body receives fewer calories or nutrients than it needs, it may redirect resources away from nonessential functions such as hair production.

This can be especially relevant when patients are not consuming enough:

  • Protein

  • Iron

  • Zinc

  • Vitamin D

  • Vitamin B12

  • Essential fatty acids

  • Overall calories

Hair shedding may begin two to four months after the nutritional or physical stress occurs.

Is Telogen Effluvium Permanent?

Telogen effluvium is often temporary.

Once the underlying trigger is corrected, the follicles can gradually return to their normal growth cycle. However, recovery takes time because hair grows slowly.

A general recovery timeline may include:

  • First few months: Continued shedding may occur

  • Three to six months: Shedding may begin to slow

  • Six to twelve months: Visible regrowth and improved density may develop

  • Longer recovery: Possible when triggers continue or another form of hair loss is also present

Some patients develop prolonged shedding when the trigger remains active or when telogen effluvium reveals underlying androgenetic alopecia.

Why Was Dutasteride Discussed?

After reviewing multiple hair-restoration options, the patient elected to begin dutasteride.

Dutasteride reduces the conversion of testosterone into dihydrotestosterone, commonly called DHT. It is generally used when a hormonal or patterned component of hair loss is suspected.

Although her examination was most consistent with telogen effluvium, treatment planning may also consider whether underlying follicle miniaturization could be contributing to reduced density.

The patient was instructed to take one 0.5 mg capsule daily.

Potential risks discussed included:

  • Reduced libido

  • Sexual side effects

  • Pregnancy-related risks

  • Other medication-related adverse effects

Dutasteride is teratogenic and should not be used during pregnancy. Patients who could become pregnant require appropriate counseling and pregnancy prevention.

Could Oral Minoxidil Be Added Later?

Oral minoxidil was discussed as a possible future treatment.

The plan was to monitor the patient’s response and potentially consider adding oral minoxidil at a follow-up visit.

Low-dose oral minoxidil may help stimulate hair follicles and prolong the active growth phase.

Possible side effects include:

  • Dizziness

  • Low blood pressure

  • Heart palpitations

  • Ankle swelling

  • Fluid retention

  • Unwanted facial or body hair

  • Shortness of breath

Because it is a systemic medication, it should only be prescribed after reviewing the patient’s cardiovascular history and other medications.

Why Was Topical Rogaine Recommended?

The patient was also advised to consider 5% topical minoxidil foam.

Topical minoxidil may help support follicles during prolonged shedding and may be particularly useful when telogen effluvium overlaps with patterned hair loss.

She was instructed to apply it directly to the scalp twice daily for four to six months, followed by a reduced maintenance schedule if appropriate.

Patients should know that:

  • Temporary early shedding may occur

  • Results require consistent use

  • Improvement usually takes several months

  • Benefits may gradually reverse after discontinuation

Minoxidil does not immediately stop telogen effluvium, but it may help encourage follicles to return to the growth phase.

What Other Treatments Were Reviewed?

The patient received counseling about several additional options.

Nutritional Supplements

Products such as Nutrafol or Viviscal may provide nutritional support, but they should not replace evaluation for iron, thyroid, protein, or other deficiencies.

Supplements are most useful when they address a real nutritional gap.

Low-Level Laser Therapy

Laser caps or helmets use low-level red light to stimulate follicles.

Possible advantages include:

  • At-home use

  • No injections

  • No systemic medication

  • Compatibility with other treatments

Consistent long-term use is generally required.

Platelet-Rich Plasma

PRP treatment uses concentrated platelets obtained from the patient’s own blood and injected into areas of thinning.

PRP may help support weakened follicles, but it is considered cosmetic and is usually not covered by insurance.

Patients typically require a series of treatments followed by maintenance sessions.

Spironolactone

Spironolactone may be considered for selected women with a hormonal component to their hair loss.

Potential side effects include:

  • Menstrual irregularities

  • Fatigue

  • Breast tenderness

  • Dizziness

  • Increased potassium

  • Increased urination

It is not appropriate during pregnancy.

Hair Transplantation

Hair transplantation is generally considered for stable, patterned hair loss rather than active, sudden telogen effluvium.

The underlying shedding should first be evaluated and controlled.

Should Patients Stop Their Weight-Loss Medication?

Patients should not stop semaglutide, tirzepatide, or another prescription medication without speaking to the clinician who prescribed it.

Instead, patients experiencing hair loss should discuss:

  • Their rate of weight loss

  • Daily protein intake

  • Calorie intake

  • Medication dose changes

  • Recent illnesses or procedures

  • Menstrual or hormonal changes

  • Laboratory testing

  • Whether another medication may be contributing

The health benefits of treatment may outweigh the temporary hair shedding, and the plan may be adjusted without stopping medication altogether.

Which Laboratory Tests May Be Helpful?

Depending on the patient’s history, a dermatologist may consider testing for:

  • Complete blood count

  • Ferritin and iron levels

  • Thyroid function

  • Vitamin D

  • Vitamin B12

  • Zinc

  • Metabolic abnormalities

  • Hormonal changes

Although this patient denied known anemia or thyroid disease, laboratory testing may still be considered if shedding continues or worsens.

What Else Was Found During Her Dermatology Visit?

In addition to hair loss, the patient had two unrelated skin concerns addressed during the visit.

A Suspicious-Looking Spot on the Back

An erythematous, scaly papule was identified on the left mid-upper back.

Because the lesion could not be diagnosed confidently by appearance alone, a shave biopsy was performed.

The differential diagnosis included:

  • An irritated seborrheic keratosis

  • Another neoplasm of uncertain behavior

The tissue was sent for microscopic evaluation. The patient was instructed to contact the office if she did not receive results within two weeks.

This part of the visit highlights the importance of evaluating unusual, changing, or irritated lesions rather than assuming they are harmless.

Multiple Plantar Warts

The patient also had seven plantar warts distributed across both feet.

These lesions were painful, contagious, and infectious.

They were treated with liquid nitrogen.

Patients were counseled that treated areas may develop:

  • Blistering

  • Crusting

  • Temporary discomfort

  • Darker or lighter pigmentation

  • Incomplete clearance

  • Recurrence

Warts are caused by a viral infection and may spread through direct contact or contaminated surfaces.

When Should You See a Dermatologist for Sudden Hair Loss?

Schedule an evaluation if you experience:

  • Sudden diffuse shedding

  • Hair loss lasting longer than several weeks

  • A rapidly shrinking ponytail

  • Hair loss after significant weight loss

  • Shedding after starting or changing medication

  • Bald patches

  • Scalp pain or burning

  • Redness or scaling

  • Eyebrow or eyelash loss

  • Symptoms of anemia or thyroid disease

A dermatologist can help distinguish temporary telogen effluvium from genetic, autoimmune, nutritional, hormonal, or scarring hair loss.

The Bottom Line

This 47-year-old woman developed sudden, generalized hair shedding after experiencing medical complications and switching from semaglutide to tirzepatide.

Her positive hair-pull test and diffuse shedding were consistent with telogen effluvium.

Several contributing factors were discussed, including medical stress, medication changes, rapid weight loss, and possible nutritional changes. After reviewing topical minoxidil, oral minoxidil, spironolactone, supplements, laser therapy, PRP, and other options, she elected to begin dutasteride and consider additional therapy at follow-up.

The most important takeaway is that sudden shedding after weight loss or a medication change is often treatable and may be temporary. Identifying the underlying trigger, supporting adequate nutrition, and receiving an accurate diagnosis can help guide recovery.

Frequently Asked Questions

Can tirzepatide cause telogen effluvium?

Hair shedding may occur in some patients using tirzepatide, often in association with rapid weight loss, reduced nutrition, physical stress, or metabolic changes rather than direct follicle damage.

Can switching from semaglutide to tirzepatide trigger hair loss?

A medication switch, changing rate of weight loss, altered appetite, and associated physical stress may contribute to telogen effluvium in susceptible patients.

How long does hair shedding after weight loss last?

Shedding often improves within several months after the trigger stabilizes, but visible density may take six to twelve months or longer to recover.

Should I stop my weight-loss medication if my hair is shedding?

Do not stop prescription medication without speaking to the prescribing clinician. Your dermatologist and prescribing provider can help evaluate nutrition, weight-loss rate, laboratory results, and treatment options.

Does a positive hair-pull test mean permanent hair loss?

No. A positive hair-pull test indicates active shedding. It does not automatically mean that the follicles are permanently damaged.

Can topical minoxidil help telogen effluvium?

Topical minoxidil may help in prolonged cases or when telogen effluvium overlaps with patterned hair loss. It should be used consistently and under medical guidance.

Is dutasteride a standard treatment for telogen effluvium?

Dutasteride targets DHT-related follicle miniaturization rather than the primary trigger of telogen effluvium. It may be considered when an underlying patterned component is suspected, but treatment should be individualized.

Can hair grow back after GLP-1-related shedding?

In many cases, yes. When the trigger is corrected and the follicles are not scarred, hair may gradually return to its normal growth cycle.



Next
Next

“I’m Almost Done With Accutane—Why Am I Still Getting Small Breakouts?”